5Davidson MH. Overview of prevention and treatment of atherosclerosis with lipid-altering therapy for pharmacy directors[ J]. Am J Manag Care ,2007,13:260-265.
6Luscher TF, Creager MA, Beckman JA, et al. Diabetes and vascular disease:pathophysiology, clinical consequences,and medical therapy: part Ⅱ[ J ]. Circulation, 2003,108 ( 13 ) : 1655 -1661.
二级参考文献11
1李健斋，中国实验诊断学杂志，1997年，1卷，11页
2血脂异常防治对策专题组，中华心血管病杂志，1997年，25卷，169页
3董军，中华医学检验杂志，1997年，20卷，52页
4李健斋，中华医学检验杂志，1997年，20卷，327页
5董军，生物化学与生物物理进展，1996年，23卷，179页
6蒋雷，中国动脉硬化杂志，1995年，3卷，153页
7Elatrozy T, Nicolaides A, Tegos T, et al. The objective characterisation of ultrasonic carotid plaque features. Eur J Vasc Endovasc Surg, 1998, 16: 223-230.
8Naylor AR, Rothwell PM, Bell P1L Overview of the principal results and secondary analyses from the European and North American randomised trials of endarterectomy for symptomatic carotid stenosis. Eur J Vasc Endovasc Surg, 2003,26: 115-129.
9Blaser T, Hofmann K, Buerger T, et al. Risk of Stroke, Transient ischemic attack, and vessel occlusion before endarterectomy in patients with symptomatic severe carotid stenosis. Stroke, 2002, 33 : 1057-1062.
10Feeley TM, Leen E J, Colgan MP, et al. Histologic characteristics of carotid artery plaque. J Vasc Surg, 1991, 13: 719-724.
